QILIAN INTERNATIONAL HOLDING (QLI) Stock Overview
USA - NASDAQ:QLI - KYG7307E1237 - Common Stock
QLI Key Statistics, Chart & Performance
The current stock price of QLI is 5.41 USD. In the past month the price increased by 26.7%. In the past year, price increased by 27.37%.
QLI Latest News, Press Relases and Analysis
QLI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.78 | 776.19B | ||
| JNJ | JOHNSON & JOHNSON | 18.01 | 450.19B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.61 | 256.13B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.95 | 238.94B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.38 | 231.28B | ||
| MRK | MERCK & CO. INC. | 11.3 | 217.38B | ||
| PFE | PFIZER INC | 7.23 | 139.30B | ||
| SNY | SANOFI-ADR | 11.55 | 124.44B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.36 | 87.16B | ||
| GSK | GSK PLC-SPON ADR | 9.75 | 87.89B | ||
| ZTS | ZOETIS INC | 23.38 | 64.44B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.36 | 44.53B |
Related stock screener links
About QLI
Company Profile
Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
Company Info
QILIAN INTERNATIONAL HOLDING
No. 152 Hongliang East 1St Street, No. 1703, Tianfu New District
Jiuquan GANSU 735000 CN
CEO: Zhanchang Xin
Employees: 298
Phone: 8609372689523
QILIAN INTERNATIONAL HOLDING / QLI FAQ
What does QILIAN INTERNATIONAL HOLDING do?
Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
What is the stock price of QILIAN INTERNATIONAL HOLDING today?
The current stock price of QLI is 5.41 USD. The price decreased by -6.08% in the last trading session.
Does QLI stock pay dividends?
QLI does not pay a dividend.
What is the ChartMill rating of QILIAN INTERNATIONAL HOLDING stock?
QLI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the upcoming dividend date for QILIAN INTERNATIONAL HOLDING?
The next ex-dividend date for QILIAN INTERNATIONAL HOLDING (QLI) is February 27, 2023.
Is QILIAN INTERNATIONAL HOLDING (QLI) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QLI.
QLI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to QLI. When comparing the yearly performance of all stocks, QLI is one of the better performing stocks in the market, outperforming 93.62% of all stocks.
QLI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to QLI. While QLI seems to be doing ok healthwise, there are quite some concerns on its profitability.
QLI Financial Highlights
Over the last trailing twelve months QLI reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS decreased by -3727.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.18% | ||
| ROE | -18.18% | ||
| Debt/Equity | 0.01 |